TwoOncDocs

🤔 Heading to #ASH26?

⭐️ Join us for a complimentary in-person Hematology Board Review for fellows & anyone prepping for boards 🩸

📅 Friday, December 11, 2026
🕗 8:00 AM–12:00 PM CT
📍 420 Julia St., New Orleans, LA
🔗 Register: bit.ly/hemeboards

Join us & @OncBrothers Dec 11 in New Orleans 8AM-12PM for a complimentary high yield interactive board review session on malignant & classical heme topics right before #ASHapalooza

Followed by a special career panel with our friend @rmistry91 from the @thefellowoncall🩸#ASH26

We released our cheat sheet of highest yield topics last week for ABIM exams coming up Nov 17&18!

🫁 Onc:
GI 13.5%
Breast 13.5%
GU 12%
Thoracic 11.5%
Together, represent over 50%

🩸 Heme:
Neoplasms make up 35%
Prioritize leukemias, lymphomas, and plasma cell disorders

GL! 🙏🏼

We are back this week with our final #breastcancer series on metastatic breast cancer 🩷

A 62yo F presents with newly diagnosed ER-positive, HER2-negative metastatic breast cancer with asymptomatic bone and nodal disease.

Which of the following is a preferred tx?

Today part 2 of our breast cancer series is out on Localized #BreastCancer 🩷

A 39yo woman with pt1c (1.5cm) ER+ breast cancer undergoes a lumpectomy with SLNB.

Which of the following adjuvant endocrine therapies is preferred in PRE menopausal women?